Seyed Jalal Hashemi

Seyed Jalal Hashemi

Auto-generated profile, based on publicly available information

Seyed Jalal Hashemi

Alimentary Tract Reseach Center, Clinical Research Institute, Imam Khomeini Hospital , Ahvaz University of Medical Sciences, Ahvaz, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JHJalal Hashemi
Jalal Hashemi
EHEskandar Hajiani
Eskandar Hajiani
HSHbb Shahbazin
Hbb Shahbazin
RMRahim Masjedizadeh
Rahim Masjedizadeh
NGNavab Ghasemi
Navab Ghasemi
To determine the prevalence of celiac disease (CD) in children with idiopathic short stature (ISS) and the diagnostic value of immunoglobulin (Ig) A G antigliadin antibodies (AGA) and transglutaminase (TTG) antibodies for CD. A total of 104 children (49 male, 55 female) with ISS without a specific etiology were studied. Extensive endocrine investigations had shown no abnormalities in any subject. Anthropometric parameters and IgA AGA and IgA TTG antibodies were evaluated in this study group. These antibodies were measured by enzyme-linked immunosorbent assay. All patients were referred for an endoscopic intestinal biopsy. The biopsy samples were classified according to revised Marsh criteria (UEGW 2001). We detected positive IgA TTG antibodies in 36 and IgA AGA in 35 of these patients. Thirty one IgA TTG antibody positive and 28 IgA AGA positive subjects showed histological abnormalities compatible with celiac disease (33.6%). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value for IgA AGA were found to be 80%, 88.4%, 77.8% and 89.7%, respectively. Sensitivity, specificity and PPV for IgA TTG antibodies were 88.6%, 94.2% and 88.6%, respectively. We conclude that the prevalence of celiac disease is high in patients with ISS and it is important to test all children with ISS for celiac disease by measuring serologic markers and performing an intestinal biopsy.

28 December 2022 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
NSNader Saki
Nader Saki
SHSeyed Jalal Hashemi
Seyed Jalal Hashemi
SHSeyed Ahmad Hosseini
Seyed Ahmad Hosseini
ZRZahra Rahimi
Zahra Rahimi
FRFakher Rahim
Fakher Rahim
BCBahman Cheraghian
Bahman Cheraghian
Background: Socioeconomic status (SES) strongly predicts morbidity and premature mortality, especially for non-communicable diseases (NCDs). However, the effect of these factors on Metabolic Syndrome (MetS) is not clear yet. This study was conducted to assess the relationship between socioeconomic indicators and MetS. Methods: In this prospective cohort study, 10,009 people aged 35–70 enrolled from May 2016 to August 2018. The MetS was defined according to The Standard National Cholesterol Education Program (NCEP)—adult treatment panel III (ATP III) or NCEP-ATP III criteria. Demographics and socioeconomic data were gathered face-to-face through trained interviews. Also, lab, anthropometrics, and blood pressure measurements were assayed for participants. Logistic regression was used to estimate the association between SES and MetS, adjusted for the potential confounding factors. Results: The overall prevalence of MetS in the participants was 39.1%. The crude odds ratios were statistically significant for all the assessed variables (p < 0.05). After adjustment for age, sex, physical activity, smoking, and alcohol use as potential confounders, the results indicated significant direct independent associations between skill level (p = 0.006) and Townsend index (p = 0.002) with MetS. In contrast, no significant associations between educational level and wealth status with MetS. Conclusion: The results of our study showed that SES is related to MetS. Among the four assessed SES indicators, skilled levels and Townsend score are strongly associated with MetS. We recommend considering people's SES when interventional programs are planned and conducted on MetS in similar communities.

21 March 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
SHSeyed Jalal Hashemi
Seyed Jalal Hashemi
EHEskandar Hajiani
Eskandar Hajiani
AMAbdolrahim Masjedizadeh
Abdolrahim Masjedizadeh
MMManoochehr Makvandi
Manoochehr Makvandi
ASAli Akbar Shayesteh
Ali Akbar Shayesteh
MKMohammad Hossein Karimi
Mohammad Hossein Karimi
Background: Chronic hepatitis B virus (HBV) infection has a broad spectrum of manifestation, ranging from silent carrier state to advanced cirrhosis and hepatocellular carcinoma. The persistence of HBV DNA in serum and hepatocytes of the cirrhotic patient could be detected by molecular techniques in spite of negative HBV serologic markers. Objectives: This case-control study was designed to evaluate the prevalence of occult HBV infection (OBI) in patients with cryptogenic liver cirrhosis in comparison with healthy subjects. Patients and Methods: Of 165 patients with liver cirrhosis, 50 consecutive patients with cryptogenic cirrhosis and 80 healthy individual without any risk factors as a control group were enrolled in this study. Their sera were tested for HBV DNA using nested PCR method. Results: Of 50 patients with cryptogenic cirrhotic, 36 (72%) were male. The mean age of patients was 53.34 ± 14.73 years; 80 healthy subjects were selected as control group with mean age of 32.65 ± 8.51 years; 7 (14%) of the patients with cryptogenic cirrhosis showed positive HBV DNA by PCR, while HBV DNA was negative for the control group (P = 0.0001); 4(57%) cases with positive HBV shown by PCR were negative for anti-HBc and anti-HBs tests. The mean level of transaminases was significantly higher in patients with cirrhosis. There were no significant differences in demographic parameters, transaminases level and degree of hepatic failure among cirrhotic patients with and without OBI. Conclusions: The prevalence of OBI was relatively high in patients with cryptogenic cirrhosis. OBI was found among the patients above 40 years old. Prospective cohort studies are needed to evaluate the clinical significance of OBI. Keywords: Liver Cirrhosis; Infection; Hepatitis B

1 January 2017 in Gastroenterology Review
Verified
Journal Article
Open access
PDF file
FZFarzad Jassemi Zergani
Farzad Jassemi Zergani
ASAli Akbar Shaiesthe
Ali Akbar Shaiesthe
EHEskandar Hajiani
Eskandar Hajiani
JHJalal Hashemi
Jalal Hashemi
RMRahim Masjedizadeh
Rahim Masjedizadeh
SSSaeid Seyyedian
Saeid Seyyedian
Introduction: Argon plasma coagulation (APC) has been reported to be effective in the treatment of solitary rectal ulcer syndrome (SRUS). However, it has not appeared to be effective in healing ulcers. Aim : This study aimed at assessing the effectiveness of APC in controlling rectal...

17 May 2017 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MBMolouk Beiromvand
Molouk Beiromvand
SHSeyed Jalal Hashemi
Seyed Jalal Hashemi
RAReza Arjmand
Reza Arjmand
NSNooshin Sadjadei
Nooshin Sadjadei
LHLeila Hardanipasand
Leila Hardanipasand
Background: Blastocystis is one of the most common anaerobic protozoa found in the intestinal tract of humans and various animals, with a worldwide distribution. The parasite has been linked to the pathogenesis of the irritable bowel syndrome (IBS), previously. Objectives: The aim of this study was to evaluate the prevalence of Blastocystis in IBS patients compared to healthy individuals. Methods: The collected feces from 152 patients with Gastrointestinal (GI) symptoms, and 130 healthy volunteers from Ahvaz, southwest Iran, were examined using the direct saline smear, Lugol’s iodine staining, and inoculated in a Jones’ medium for Blastocystis detection. The DNA was extracted from all culture-positive samples, and then the polymerase chain reaction (PCR) was performed by the SSU-rDNA gene. Results: Blastocystis was identified in 18 (6.4%) samples, including two (1.3%) of the IBS patients and 16 (12.3%) of the control group by microscopy. Stool culture was positive in 15 with IBS, one without IBS, and 40 control samples. From these, the expected 600 bp fragments of the SSU-rDNA gene were identified in 15 (27.3%) cases and 40 (72.7%) controls. Subtypes (STs) 1, 2, and 3 were identified from the 54 successfully sequenced samples. Subtype 3 was the most common ST with the frequency of 46.3%, followed by ST2, 37% and ST1, 16.7% in the case and control groups. The highest frequency of Blastocystis STs (27.8%) was identified in the age group of 31-40 years and the lowest was found in the age groups of under 10 years and over 81 years. Conclusions: The findings of the current study showed that Blastocystis was more common in the control group compared to the IBS patients. Therefore, our findings highlight the contrast between Blastocystis infection and GI disorders. Furthermore, these results support the hypothesis that Blastocystis could be a GI health marker. Keywords: Subtype; IBS; Iran; Blastocystis

MMMehdi Mohamadnejad
Mehdi Mohamadnejad
SHSayed Jalal Hashemi
Sayed Jalal Hashemi
FZFarhad Zamani
Farhad Zamani
MBMassoud Baghai-Wadji
Massoud Baghai-Wadji
RMReza Malekzadeh
Reza Malekzadeh
MEMohamad A. Eloubeidi
Mohamad A. Eloubeidi
Background and study aims: Stones in the cystic duct stump (CDS) or gallbladder remnant after cholecystectomy are difficult to identify. The aim of this study was to evaluate the utility of endoscopic ultrasound (EUS) in the diagnosis of stones in the CDS or gallbladder remnant in patients with postcholecystectomy syndrome. Methods: A prospective study was conducted between January 2011 and December 2012 in consecutive patients with pancreaticobiliary-type pain or acute pancreatitis (n = 112) following cholecystectomy. Diagnostic modalities including EUS were used to diagnose the cause of postcholecystectomy syndrome. Results: A total of 11 patients (10 %) were found to have stones in the gallbladder remnant (n = 8), CDS (n = 2), or both (n = 1). In eight patients, EUS was the first imaging procedure to make the diagnosis. Seven patients agreed to undergo repeat surgery, and six of them remained free of symptoms postoperatively after a median follow-up period of 4 months (range 1 – 13 months). Conclusion: EUS may be an important procedure to consider in the study of patients with symptoms after cholecystectomy, as the diagnosis of residual stones is frequently missed by other imaging modalities.